Upperton Opens New Development and GMP Manufacturing Facility
Upperton Pharma Solutions was joined by Sarah Gilbert, Professor and co-creator of the Oxford/AstraZeneca COVID-19 vaccine for the official opening of its new development and GMP manufacturing facility in Nottingham, UK.
UK-based contract development and manufacturing organization (CDMO) Upperton Pharma Solutions recently celebrated the official opening of a new 50,000 square foot development and GMP manufacturing facility in Nottingham.
Nikki Whitfield, CEO of Upperton Pharma Solutions, commented, “This celebration marks another milestone in our incredible growth journey as a business. We are looking forward to officially opening our doors to customers and offering a single site solution for development and GMP manufacturing.”
The new facility contains ten GMP manufacturing suites, cutting-edge quality control laboratories, and formulation development capabilities equipped with a pilot plant. The facility enables Upperton to offer customers early formulation development to clinical trial supplies from Phase 1 to Phase 3 and niche scale commercial manufacturing all on one site.
“It was a pleasure to join Upperton for the grand opening of their new facility”, said Sarah Gilbert, co-creator of the Oxford/AstraZeneca COVID-19 vaccine. “During the pandemic we saw the importance of academia and industry working closely together to deliver life-saving vaccines and treatments. Upperton’s expansion into this new site is a great example of the crucial role UK-based pharmaceutical organisations have to play in addressing global health challenges. I look forward to collaborating with Upperton in the future.”
The official opening marks another milestone for Upperton following the announcement and ongoing build of a new sterile facility on the same site, for the manufacturing of aseptic and terminally sterilized small-volume liquids for parenteral, ocular, and pulmonary delivery due for completion at the end of 2024.
Company
Upperton Pharma SolutionsAlbert Einstein Centre, Nottingham Science Park
NG7 2TN Nottingham
UK
most read
VCI Welcomes US-EU Customs Deal
The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.
Jens Birgersson Becomes New Brenntag CEO
Jens Birgersson becomes new Brenntag CEO
Oxea Returns to its Roots
Oxea is returning to its old name and its roots.
Supply Chain and Logistics Trends in the Chemical Industry
This interview covers key results of the study ‘Success Factor Supply Chain Management and Logistics in the Chemical Industry 2024’ by Solventure, Aimms and Miebach.
Honeywell to Acquire Johnson Matthey's Catalyst Technologies Business
Honeywell will acquire Johnson Matthey's Catalyst Technologies business segment for €2.15 billion in an all-cash transaction.